| Literature DB >> 32351215 |
Tien-Li Lan1, Fong-In Chou2, Ko-Han Lin3, Po-Shen Pan4, Jia-Cheng Lee5, Wen-Sheng Huang3, Yu-Ming Liu5, Yee Chao6, Yi-Wei Chen7.
Abstract
Radiation therapy has an irreplaceable role in modern oncologic therapy, thanks to the advanced radiation techniques developed in recent decades. However, photon-resistant cases are sometimes encountered. Boron Neutron Capture Therapy (BNCT) is a highly selective radiotherapy technique due to the high tumor to tissue ratio of boronophenylalanine (BPA), the unique medication used for the BNCT treatment reaction. In this study, we report on three special patients with malignant brain tumors treated with BNCT.Entities:
Keywords: Boron Neutron Capture Therapy; Mismatch repair syndrome; Recurrent glioblastoma
Mesh:
Year: 2020 PMID: 32351215 DOI: 10.1016/j.apradiso.2020.109105
Source DB: PubMed Journal: Appl Radiat Isot ISSN: 0969-8043 Impact factor: 1.513